BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5332263)

  • 21. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate).
    Braunsteiner H; Herbst M; Sandhofer F; Sailer S
    Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypolipidemic agents--newly approved.
    Duncan GG
    Pa Med; 1967 Aug; 70(8):75-6. PubMed ID: 6073724
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B; Monnier J
    Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
    [No Abstract]   [Full Text] [Related]  

  • 24. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M; Cottet J; Etienne J; Loeper J
    Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of platelet stickiness tests during an atromid-S trial.
    O'Brien JR; Heywood JB
    Thromb Diath Haemorrh; 1966 Dec; 16(3):768-77. PubMed ID: 5996687
    [No Abstract]   [Full Text] [Related]  

  • 26. [Atromid].
    Borchgrevink CF
    Tidsskr Nor Laegeforen; 1967 Mar; 87(5):334. PubMed ID: 6039533
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of atromid or CPIB treatment with and without androsterone in hyperlipemia (110 therapeutic trials in 2 years)].
    de Gennes JL; Maunand B; Salmon ; Laudat P; Truffert J
    Bull Mem Soc Med Hop Paris; 1965 Apr; 116(8):759-84. PubMed ID: 5834264
    [No Abstract]   [Full Text] [Related]  

  • 28. [Action of ethyl chlorophenoxyisobutyrate on several types of hyperlipidemia].
    Beaumont V; Swynghedauw B; Beaumont JL; Himbert J
    Rev Atheroscler (Paris); 1966; 8(1):12-20. PubMed ID: 5961026
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of essential hyperlipemia treated with atromid].
    Baczko A; Ciƛwicka-Sznajderman M; Jakubowicz K; Sznajderman M
    Kardiol Pol; 1965; 8(2):135-41. PubMed ID: 5836657
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease.
    Carson P; McDonald L; Pickard S; Pilkington T; Davies B; Love F
    Br Heart J; 1966 May; 28(3):400-3. PubMed ID: 5936972
    [No Abstract]   [Full Text] [Related]  

  • 31. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
    Oliver MF
    Bull N Y Acad Med; 1968 Aug; 44(8):1021-7. PubMed ID: 4875747
    [No Abstract]   [Full Text] [Related]  

  • 32. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
    Bertulla A; Bertamino V; Solari E
    Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
    [No Abstract]   [Full Text] [Related]  

  • 33. Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Metabolism; 1968 May; 17(5):457-73. PubMed ID: 5648211
    [No Abstract]   [Full Text] [Related]  

  • 34. Communications. Action of Atromid-S (clofibrate) on intra-ocular pressure.
    Gloster J; Hartley RE; Perkins ES
    Br J Ophthalmol; 1968 Nov; 52(11):793-800. PubMed ID: 4972749
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S; Paparella P; Seu V
    Clin Ter; 1969 Jul; 50(1):11-26. PubMed ID: 4917326
    [No Abstract]   [Full Text] [Related]  

  • 36. Controlled clinical trial of "Atromid" (androsterone with ethyl-p-chlorophenoxy-isobutyrate) and "Persantin" (dipyridamole) in cases of myocardial infarction.
    Teik KO; Poh FW; Fun CS; Mong BC
    Med J Malaya; 1966 Mar; 20(3):186-204. PubMed ID: 4223070
    [No Abstract]   [Full Text] [Related]  

  • 37. Retinal vein occlusion. A comparative study of factors affecting the prognosis, including a therapeutic trial of Atromid S in this condition.
    Clements DB; Elsby JM; Smith WD
    Br J Ophthalmol; 1968 Feb; 52(2):111-6. PubMed ID: 5642658
    [No Abstract]   [Full Text] [Related]  

  • 38. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of Atromid treatment of patients with essential hyperlipidemia and xanthomatosis].
    Baranova LV
    Ter Arkh; 1967 Jul; 39(7):61-3. PubMed ID: 5610932
    [No Abstract]   [Full Text] [Related]  

  • 40. Familial hypercholesterolaemic xanthomatosis and coronary heart disease in a ten-year-old girl.
    Miettinen M
    Ann Paediatr Fenn; 1967; 13(1):35-8. PubMed ID: 6079714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.